EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological Analyses of Chronic Renal Allograft Arteriopathy after Kidney Transplantation

Tomokazu Shimizu, Kazuya Omoto, Masashi Inui, Taiji Nozaki, Toshio Takagi, Hideki Ishida

Nephron · 2023

DOI: 10.1159/000531177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron, 2023. Verfasst von Tomokazu Shimizu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplant Surgery, Toda Chuo General Hospital, Saitama, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Vascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Herein, we discuss clinicopathological analyses of cases of chronic renal allograft arteriopathy (CRA) after renal transplantation and clarify the mechanisms underlying the development and prognostic significance of CRA.

Methods

CRA was diagnosed in 34 renal allograft biopsy specimens (BSs) obtained from 27 renal transplant patients who were followed up at the Department of Urology and Transplant Surgery, Toda Chuo General Hospital, between January 2010 and December 2020.

Results

CRA was diagnosed at a median of 33.4 months post-transplantation. Of the 27 patients, 16 had a history of rejection. Among the 34 BSs showing evidence of CRA, CRA was mild (cv1 in Banff’s classification) in 22, moderate (cv2) in 7, and severe (cv3) in 5 patients. We then classified the 34 BSs showing evidence of CRA based on their overall histopathological features as follows: cv alone seen in 11 (32%) BSs, cv + antibody-mediated rejection (AMR) in 12 (35%), and cv + T-cell-mediated rejection (TCMR) in 8 (24%). Loss of the renal allograft occurred during the observation period in 3 patients (11%). Of the remaining patients with functioning grafts, deterioration of renal allograft function after biopsies occurred in 7 cases (26%).

Conclusions

Our study results suggest that AMR contributes to CRA in 30–40% of cases, TCMR in 20–30% of cases, isolated v lesions in 15% of cases, and cv lesions alone in 30%. The intimal arteritis was a prognostic factor in CRA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationVascular DiseasesHumansKidneyTransplantation, HomologousAntibodiesAllograftsGraft RejectionBiopsy

Stichwörter der Autor:innen

Chronic renal allograft arteriopathyKidney transplantationRenal allograft biopsyVascular fibrous intimal thickening

Substanzen

Antibodies

Autor:innen und Institutionen

  • Department of Transplant Surgery, Toda Chuo General Hospital, Saitama, Japan.
  • Department of Urology, Toda Chuo General Hospital, Saitama, Japan.
  • Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Urology, Tokyo Women's Medical University, Yachiyo Medical Center, Chiba, Japan.
  • Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan.

Zitieren

APA

Shimizu, T., Omoto, K., Inui, M., Nozaki, T., Takagi, T., & Ishida, H. (2023). Clinicopathological Analyses of Chronic Renal Allograft Arteriopathy after Kidney Transplantation. Nephron. https://doi.org/10.1159/000531177

Vancouver

Shimizu T, Omoto K, Inui M, Nozaki T, Takagi T, Ishida H. Clinicopathological Analyses of Chronic Renal Allograft Arteriopathy after Kidney Transplantation. Nephron. 2023. doi:10.1159/000531177

BibTeX
@article{Shimizu2023,
  author = {Shimizu, Tomokazu and Omoto, Kazuya and Inui, Masashi and Nozaki, Taiji and Takagi, Toshio and Ishida, Hideki},
  title = {Clinicopathological Analyses of Chronic Renal Allograft Arteriopathy after Kidney Transplantation},
  journal = {Nephron},
  year = {2023},
  doi = {10.1159/000531177}
}
Kostenlos starten →